Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis. (Q43207229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

3

Laura Bannach Jardim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

10

Roberto Giugliani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

Dafne Dain Gandelman Horovitz

15 January 2020

2

object named as

Dafne Dain Gandelman Horovitz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

María Verónica Muñoz-Rojas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Marcia Raymundo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Tatiana de Sá Carneiro Pacheco de Magalhães

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Taiane Alves Vieira

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ronaldo Costa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Emil Kakkis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

5 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

346-350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Cervical cord compression in mucopolysaccharidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Cervical myelopathy due to dural compression in mucopolysaccharidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Multilevel myelopathy in Maroteaux-Lamy syndrome and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Origin of DSS: to present the plan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Management guidelines for mucopolysaccharidosis VI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Enzyme replacement therapy in a feline model of MPS VI: modification of enzyme structure and dose frequency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Spinal cord compression in Morquio-Brailsford's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Spastic quadriparesis due to C1–C2 subluxation in hurler syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

The interobserver reliability of the revised American Spinal Injury Association standards for neurological classification of spinal injury patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.11.008

10.1016/J.YMGME.2009.11.008

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20036175%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference